Genesis Global Group

You will now be redirected to the GD3 website

PharmOptima is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3


Our bioanalytical services goal is to meet your project schedules and providing the highest quality data to facilitate decisions concerning your drug candidate. Our scientists are skilled in method development, validation, and sample analysis of small and large molecular weight compounds, metabolites, and peptides in biological matrices using liquid chromatography with tandem mass spectrometry (LC-MS/MS). We have three different LC/MS platforms (SCIEX 5000, SCIEX 4000, Thermo TSQ Quantum Ultra). Analyses can be conducted following FDA GLP guidelines, as needed.

What we can do for you:

  • rapid screening bioanalytical methods
  • method development, validation, and sample analysis following FDA GLP and OECD guidances
  • preclinical pharmacokinetics
  • PK/PD assessment
  • toxicokinetics
  • bioavailability/bioequivalence
  • Ocular, prodrug and metabolite PK